Document:

EXHIBIT 10.3

                      AGREEMENT AND PLAN OF REORGANIZATION

                                  BY AND AMONG

                           PATHBIOTEK DIAGNOSTICS INC.
                               A TEXAS CORPORATION

                                       AND

                                   ATNG, INC.
                              A NEVADA CORPORATION

                                       AND

                             ATNG ACQUISITION, INC.
                              A TEXAS CORPORATION

                             DATED: AUGUST 24TH, 2001
                                           ----

<PAGE>
                      AGREEMENT AND PLAN OF REORGANIZATION
                      ------------------------------------

                          PATHOBIOTEK DIAGNOSTICS INC.
                                       AND
                                   ATNG, INC.
                                       AND
                             ATNG ACQUISITION, INC.

     This Agreement and Plan of Reorganization ("Agreement"), dated as of August
24th 2001, among PATHOBIOTEK DIAGNOSTICS INC. (Patho), a Texas Corporation,
----
ATNG, Inc., a Nevada Corporation, ATNG ACQUISITION, INC. (Acquisition), a Texas
Corporation, and the shareholders of ATNG ("ATNG Shareholders") who will join
this agreement by execution.

                              W I T N E S S E T H:

     A.   WHEREAS, Patho and ATNG are corporations duly organized under the laws
of the State of Texas and Nevada, respectively. ATNG Acquisition, Inc., a Texas
corporation is a wholly owned subsidiary of Patho.

     B.   Plan of Reorganization. The ATNG Shareholders are the owners of all of
          ----------------------
the issued and outstanding common stock of ATNG. It is the intention that all of
the issued and outstanding stock of ATNG shall be acquired by Acquisition in
exchange solely for common stock of Patho. For federal income tax purposes it is
intended that this exchange shall qualify as a reorganization within the meaning
of SEC 368 (a)(1)(B) of the Internal Revenue Code of 1986, as amended (the
"Code").

     C.   Exchange of Shares. Patho and the ATNG Shareholders agree that all of
          ------------------
the common shares issued and outstanding of ATNG shall be acquired by
Acquisition in exchange for 27,836,186 shares of the common stock of Patho. The
pro rata numbers of the Patho shares, on the closing date, shall be delivered to
the individual shareholders in exchange for their ATNG shares as hereinafter set
forth.

     D.   WHEREAS, the parties hereto wish to enter into this Agreement,
pursuant to the provisions of the Texas Statutes.

     E.   Immediately after closing hereunder ATNG and Acquisition shall file
Articles of Merger whereby ATNG is merged into Acquisition with ATNG being the
survivor.

     F.   On the date of delivery of audits of ATNG, Patho and ATNG shall merge
in a parent/sub merger.

<PAGE>
     NOW, THEREFORE, it is agreed among the parties as follows:

                                    ARTICLE I

                                THE CONSIDERATION
                                -----------------

     1.1  Subject to the conditions set forth herein on the "Effective Date" (as
herein defined), Shareholders of ATNG shall surrender all of their shares of
ATNG for 27,836,186 common shares of Patho common stock. The transactions
contemplated by this Agreement shall be completed at a closing ("Closing") on a
closing date ("Closing Date") which shall be 90 days after date hereof.

     On the Closing Date, all of the documents to be furnished to Patho and
ATNG, including the documents to be furnished pursuant to Article VII of this
Agreement, shall be delivered to M. A. Littman, to be held in escrow until the
Effective Date or the date of termination of this Agreement, whichever first
occurs, and thereafter shall be promptly distributed to the parties as their
interests may appear.

     1.2  At the Effective Date, ATNG shall become a wholly owned subsidiary of
Acquisition. ATNG's shareholders shall receive pro rata shares of $.0001 par
value voting common stock of Patho as follows:

     Patho shall issue 27,836,186 of its shares of common stock for 100% of the
outstanding common shares of ATNG, pro rata to the shareholders of ATNG.

     1.3  If this Agreement is duly adopted by the holders of the requisite
number of shares of ATNG, in accordance with the applicable laws and subject to
the other provisions hereof, such documents as may be required by law to
accomplish the Agreement shall be filed as required by law to effectuate same,
and it shall become effective. The time of filing the last document required by
law shall be the Effective Date for the Agreement. For accounting purposes, the
Agreement shall be effective as of 12:01 a.m., on the last day of the month
preceding the Effective Date.

     1.4  On or before October 15, 2001, ATNG shall have paid $250,000 to Patho
(less prior advances) to cover expenses incurred by Patho.

                                   ARTICLE II

                         ISSUANCE AND EXCHANGE OF SHARES
                         -------------------------------

     2.1  The shares of $.0001 par value common stock of Patho shall be issued
by it to ATNG shareholders at closing.

     2.2  ATNG represents that no outstanding options or warrants for its
unissued shares exist, except as shown hereafter. All preferred stock of ATNG
due for redemption as of the date hereof shall have been redeemed as of closing
date, if any.

<PAGE>
<TABLE>
<CAPTION>
     Outstanding Warrants and Options:
<S>                                   <C>
Harrison Douglas                      W-  200,000 Shares @ $7.20 per Share
Dish Network                          W-5,000,000 Shares @ $7.20 per Share
Premiere Radio Networks Broadcasting  O-  500,000 Shares @ $6.00 per Share
Employees and Others                  O-3,200,000 Shares @ TBD
<FN>
W=Warrants
O=Options
</TABLE>

     2.3  The stock transfer books of ATNG shall be closed on the Effective
Date, and thereafter no transfers of the stock of ATNG shall be made. ATNG shall
appoint an exchange agent ("Exchange Agent"), to accept surrender of the
certificates representing the common shares of ATNG, and to deliver in exchange
for such surrendered certificates, shares of common stock of Patho. The
authorization of the Exchange Agent may be terminated by Patho after six months
following the Effective Date. Upon termination of such authorization, any shares
of ATNG and any funds held by the Exchange Agent for payment to ATNG
shareholders pursuant to this Agreement shall be transferred to Patho or its
designated agent who shall thereafter perform the obligations of the Exchange
Agent. If outstanding certificates for shares of ATNG are not surrendered or the
payment for them not claimed prior to such date on which such payments would
otherwise escheat to or become the property of any governmental unit or agency,
the unclaimed items shall, to the extent permitted by abandoned property and
other applicable law, become the property of Patho (and to the extent not in its
possession shall be paid over to it), free and clear of all claims or interest
of any persons previously entitled to such items. Notwithstanding the foregoing,
neither the Exchange Agent nor any party to this Agreement shall be liable to
any holder of ATNG shares for any amount paid to any governmental unit or agency
having jurisdiction of such unclaimed item pursuant to the abandoned property or
other applicable law of such jurisdiction.

     2.4  No fractional shares of Patho stock shall be issued as a result of the
Agreement. Shares shall be rounded to nearest whole share,

     2.5  At the Effective Date, each holder of a certificate or certificates
representing common shares of ATNG, upon presentation and surrender of such
certificate or certificates to the Exchange Agent, shall be entitled to receive
the consideration set forth herein, except that holders of those shares as to
which dissenters' rights shall have been asserted and perfected pursuant to
Nevada law shall not be converted into shares of Patho common stock, but shall
represent only such dissenters' rights. Upon such presentation, surrender, and
exchange as provided in this Section 2.5, certificates representing shares of
ATNG previously held shall be canceled. Until so presented and surrendered, each
certificate or certificates which represented issued and outstanding shares of
ATNG at the Effective Date shall be deemed for all purposes to evidence the
right to receive the consideration set forth in Section 1.2 of this Agreement.
If the certificates representing shares of ATNG have been lost, stolen,
mutilated or destroyed,

<PAGE>
the Exchange Agent shall require the submission of an indemnity agreement and
may require the submission of a bond in lieu of such certificate.

                                   ARTICLE III

                           REPRESENTATIONS. WARRANTIES
                           ---------------------------
                              AND COVENANTS OF ATNG
                              ---------------------

     No representations or warranties are made by any director, officer,
employee or shareholder of ATNG as individuals, except as and to the extent
stated in this Agreement or in a separate written statement (the "ATNG
Disclosure Statement"), if any. ATNG hereby represents, warrants and covenants
to Patho except as stated in the ATNG Disclosure Statement, as follows:

     3.1  ATNG is a corporation duly organized, validly existing and in good
standing under the laws of the State of Nevada, and has the corporate power and
authority to own or lease its properties and to carry on its business as it is
now being conducted. The Articles of Incorporation and Bylaws of ATNG are
complete and accurate, and the minute books of ATNG contain a record, which is
complete and accurate in all material respects, of all meetings, and all
corporate actions of the shareholders and board of directors of ATNG.

     3.2  The aggregate number of shares which ATNG is authorized to issue is
50,000,000 Class A shares of common stock of which 27,836,186 shares are or will
be issued and outstanding on the Effective Date.

     3.3  ATNG has complete and unrestricted power to enter into and, upon the
appropriate approvals as required by law, to consummate the transactions
contemplated by this Agreement.

     3.4  Neither the making of nor the compliance with the terms and provisions
of this Agreement and consummation of the transactions contemplated herein by
ATNG will conflict with or result in a breach or violation of the Articles of
Incorporation or Bylaws of ATNG.

     3.5  The execution, delivery and performance of this Agreement has been
duly authorized and approved by ATNG's Board of Directors.

     3.6  ATNG will deliver to Patho consolidated audited financial statements
of ATNG, as of December 31, 2000, within 60 days of date hereof. All such
statements, herein sometimes called "ATNG Financial Statements," are complete
and correct in all material respects and, together with the notes to these
financial statements, present fairly the financial position and results of
operations of ATNG for the periods included. The said statements will have been
prepared in accordance with generally accepted accounting principles. Interim
unaudited financial statements of ATNG shall be provided within 5 days after
delivery of audited financial statements.

<PAGE>
     3.7  Since the dates of the ATNG Financial Statements, there have not been
any material adverse changes in the business or condition, financial or
otherwise of ATNG.

     3.8  There are no legal proceedings or regulatory proceedings involving
material claims pending, or to the knowledge of the officers of ATNG, threatened
against ATNG or affecting any of its assets or properties, except an employee
dismissal suit has been filed by James Crunk, Former CFO, and ATNG is not in any
material breach or violation of or default under any contract or instrument to
which ATNG is a party, and no event has occurred which with the lapse of time or
action by a third party could result in a material breach or violation of or
default by ATNG under any contract or other instrument to which ATNG is a party
or by which it or any of its properties may be bound or affected, or under its
respective Articles of Incorporation or Bylaws, nor is there any court or
regulatory order pending, applicable to ATNG.

     3.9  All liability of ATNG has been properly provided for and is adequate
to comply with all regulatory requirements regarding same.

     3.10 The representations and warranties of ATNG shall be true and correct
as of the date hereof and as of the Effective Date.

     3.11 ATNG has no employee benefit plan, including non-qualified stock
awards, options, and consulting fees for independent contractors.

     3.12 No representation or warranty by ATNG in this Agreement, the ATNG
Disclosure Statement or any certificate delivered pursuant hereto contains any
untrue statement of a material fact or omits to state any material fact
necessary to make such representation or warranty not misleading.

     3.13 Intellectual Property. All trade names, inventions, discoveries,
          ---------------------
ideas, research, engineering, methods, practices, processes, systems, formulae,
designs, drawings, products, projects, improvements, developments, know-how, and
trade secrets which are used in the conduct of ATNG's business, whether
registered or unregistered (collectively the "Proprietary Rights") are owned by
ATNG. To the knowledge of ATNG, ATNG created or developed such Proprietary
Rights and such Proprietary Rights are not subject to any restriction, lien,
encumbrance, right, title or interest in others. All of the foregoing
Proprietary Rights that are not in the public domain stand solely in the name of
ATNG and not in the name of any shareholder, director, officer, agent, partner
or employee or anyone else known to ATNG and none of the same have any right,
title, interest, restriction, lien or encumbrance therein or thereon or thereto.
To the knowledge of ATNG, ATNG's ownership and use of the Proprietary Rights do
not and will not infringe upon, conflict with or violate in any material respect
any patent, copyright, trade secret or other lawful proprietary right of any
other party, and no claim is pending or, to the knowledge of ATNG, threatened to
the effect that the operations of ATNG infringe upon or conflict with the
asserted rights of any other person under any of the Proprietary Rights, and to
the knowledge of ATNG there is no reasonable basis for any such claim (whether
or not pending or threatened). No claim is pending, or to the knowledge of each
Seller and ATNG, threatened to the

<PAGE>
effect that any such Proprietary Rights owned or licensed by ATNG, or which ATNG
otherwise has the right to use, is invalid or unenforceable by ATNG and there is
no reasonable basis for any such claim (whether or not pending or threatened).
ATNG has not granted or assigned to any other person or entity any right to
manufacture, have manufactured, assemble or sell the products or proposed
products.

     3.14 a.   Liens. Except as disclosed on Schedule 3.14(a), no one other than
               -----
Seller has any right, title, interest, lien, claim, security interest,
restriction or encumbrance in, on or to ATNG's assets.

          b.   Material Contracts. Other than as disclosed on Schedule 3.14(b),
               ------------------
Seller does not have any material obligation, contract, agreement, lease,
sublease, commitment or understanding of any kind, nature or description, oral
or written, fixed or contingent due or to become due, existing or inchoate.

          c.   No Undisclosed Liabilities. ATNG does not have any material
               --------------------------
liabilities or obligations, including, without limitation, contingent
liabilities for the performance of any obligation, except for (i) liabilities or
obligations which are disclosed or fully provided for in ATNG's Financial
Statements, (ii) liabilities or obligations disclosed in this Agreement or in
any Schedules to this Agreement, and (iii) liabilities not in excess of $25,000
in the aggregate.

          d.   Environmental Matters.    (i)  ATNG has not received notice of
               ---------------------
any violation of or investigation relating to any environmental or pollution
law, regulation, or ordinance with respect to assets now or previously owned or
operated by ATNG that has not been fully and finally resolved; (ii) All permits,
licenses and other authorizations which are required under United States,
federal, state, provincial and local laws with respect to pollution or
protection of the environment ("Environmental Laws") relating to assets now
owned or operated by ATNG or any of its subsidiaries, including Environmental
Laws relating to actual or threatened emissions, discharges or releases of
pollutants, contaminants or hazardous or toxic materials or wastes
("Pollutants"), have been obtained and are effective, and, with respect to
assets previously owned or operated by ATNG, were obtained and were effective
during the time of ATNG's operation; (iii) To the knowledge of ATNG, no
conditions exist on, in or about the properties now or previously owned or
operated by ATNG or any third-party properties to which any Pollutants generated
by ATNG were sent or released that could give rise on the part of ATNG to
liability under any Environmental Laws, claims by third parties under
Environmental Laws or under common law or the occurrence of costs to avoid any
such liability or claim; and (iv) to the knowledge of ATNG, all operators of
ATNG's assets are in compliance with all terms and conditions of such
Environmental Laws, permits, licenses and authorizations, and are also in
compliance with all other limitations, restrictions, conditions, standards,
prohibitions, requirements, obligations, schedules and timetables contained in
such laws or contained in any regulation, code, plan, order, decree, judgment,
notice or demand letter issued, entered, promulgated or approved thereunder,
relating to ATNG's assets.

<PAGE>
                                   ARTICLE IV

                  REPRESENTATIONS. WARRANTIES AND COVENANTS OF
                  --------------------------------------------
                          PATHOBIOTEK DIAGNOSTICS INC.
                          ----------------------------

     No representations or warranties are made by any director, officer,
employee or shareholder of Patho as individuals, except as and to the extent
stated in this Agreement or in a separate written statement.

     Patho hereby represents, warrants and covenants to ATNG, except as stated
in the Patho Disclosure Statement, as follows;

     4.1  Patho is a corporation duly organized, validly existing and in good
standing under the laws of the State of Texas, and has the corporate power and
authority to own or lease its properties and to carry on its business as it is
now being conducted. The Articles of Incorporation and Bylaws of Patho, copies
of which have been delivered to ATNG, are complete and accurate, and the minute
books of Patho contain a record, which is complete and accurate in all material
respects, of all meetings, and all corporate actions of the shareholders and
Board of Directors of Patho.

     4.2  The aggregate number of shares which Patho is authorized to issue is
20,000,000 shares (now being changed to 100,000,000 shares) of common stock with
a par value of $.0001 per share, of which 587,000 shares (post reverse split) of
such common stock will be issued and outstanding, fully paid and non-assessable,
prior to closing under this agreement. Patho has no outstanding options,
warrants or other rights to purchase, or subscribe to, or securities convertible
into or exchangeable for any shares of capital stock. No preferred stock of
Patho is outstanding.

     4.3  Patho has complete and unrestricted power to enter into and, upon the
appropriate approvals as required by law, to consummate the transactions
contemplated by this Agreement.

     4.4  Patho owns 100% of the issued and outstanding shares of Acquisition at
the date hereof.

     4.5  Neither the making of nor the compliance with the terms and provisions
of this Agreement and consummation of the transactions contemplated herein by
Patho will conflict with or result in a breach or violation of the Articles of
Incorporation or Bylaws of Patho.

     4.6  The execution of this Agreement has been duly authorized and approved
by Patho's Board of Directors.

     4.7  Patho has delivered to ATNG financial statements of Patho dated
December 31, 2000. All such statements, herein sometimes called "Patho Financial
Statements"

<PAGE>
are (and will be) complete and correct in all material respects and, together
with the notes to these financial statements, present fairly the financial
position and results of operations of Patho of the periods indicated. All
statements of Patho will have been prepared in accordance with generally
accepted accounting principles.

     4.8  Since the dates of the Patho Financial Statements, there have not been
any material adverse changes in the business or condition, financial or
otherwise, of Patho. Patho does not have any material liabilities or
obligations, secured or unsecured except as shown on updated financials (whether
accrued, absolute, contingent or otherwise).

     4.9  Patho has delivered to ATNG a list and description of all pending
legal proceedings involving Patho, none of which will materially adversely
affect them, and, except for these proceedings, there are no legal proceedings
or regulatory proceedings involving material claims pending, or, to the
knowledge of the officers of Patho, threatened against Patho or affecting any of
its assets or properties, and Patho is not in any material breach or violation
of or default under any contract or instrument to which Patho is a party, and no
event has occurred which with the lapse of time or action by a third party could
result in a material breach or violation of or default by Patho under any
contract or other instrument to which Patho is a party or by which they or any
of their respective properties may be bound or affected, or under their
respective Articles of Incorporation or Bylaws, nor is there any court or
regulatory order pending, applicable to Patho.

     4.10 Patho shall not enter into or consummate any transactions prior to the
Effective Date other than in the ordinary course of business and will pay no
dividend, or increase the compensation of officers and will not enter into any
agreement or transaction which would adversely affect its financial condition.

     4.11 Patho is not a party to any contract performable in the future except
its land lease obligation which will not adversely affect it.

     4.12 The representations and warranties of Patho shall be true and correct
as of the date hereof and as of the Effective Date.

     4.13 Patho has delivered, or will deliver within two weeks of the date of
this Agreement, to ATNG, all of its corporate books and records for review, true
and correct copies of Patho tax returns since 1996, if any. Patho will also
deliver to ATNG on or before the Closing Date any reports relating to the
financial and business condition of Patho which occur after the date of this
Agreement and any other reports sent generally to its shareholders after the
date of this Agreement.

     4.14 Patho has no employee benefit plan in effect at this time.

     4.15 No representation or warranty by Patho in this Agreement, the Patho
Disclosure Statement or any certificate delivered pursuant hereto contains any
untrue statement of a material fact or omits to state any material fact
necessary to make such representation or warranty not misleading.

<PAGE>
     4.16 Patho agrees that all rights to indemnification now existing in favor
of the employees, agents, directors or officers of ATNG and its subsidiaries, as
provided in the Articles of Incorporation or Bylaws or otherwise in effect on
the date hereof shall survive the transactions contemplated hereby in accordance
with their terms, and Patho expressly assumes such indemnification obligations
of ATNG.

                                    ARTICLE V

              OBLIGATIONS OF THE PARTIES PENDING THE EFFECTIVE DATE
              -----------------------------------------------------

     5.1  This Agreement shall be duly submitted to the shareholders of ATNG for
the purpose of considering and acting upon this Agreement in the manner required
by law at a meeting of shareholders on a date selected by ATNG, such date to be
the earliest practicable date. The Board of Directors of ATNG, subject to its
fiduciary obligations to shareholders, shall use its best efforts to obtain the
requisite approval of ATNG shareholders of this Agreement and the transactions
contemplated herein. ATNG and Patho shall take all reasonable and necessary
steps and actions to comply with and to secure ATNG shareholder approval of this
Agreement and regulations of such states.

     5.2  At all times prior to the Effective Date during regular business
hours, each party will permit the other to examine its books and records and the
books and records of its subsidiaries and will furnish copies thereof on
request. It is recognized that, during the performance of this Agreement, each
party may provide the other parties with information which is confidential or
proprietary information. During the term of this Agreement, and for four years
following the termination of this Agreement, the recipient of such information
shall protect such information from disclosure to persons, other than members of
its own or affiliated organizations and its professional advisers, in the same
manner as it protects its own confidential or proprietary information from
unauthorized disclosure, and not use such information to the competitive
detriment of the disclosing party. In addition, if this Agreement is terminated
for any reason, each party shall promptly return or cause to be returned all
documents or other written records of such confidential or proprietary
information, together with all copies of such writings and, in addition, shall
either furnish or cause to be furnished, or shall destroy, or shall maintain
with such standard of care as is exercised with respect to its own confidential
or proprietary information, all copies of all documents or other written records
developed or prepared by such party on the basis of such confidential or
proprietary information. No information shall be considered confidential or
proprietary if it is (a) information already in the possession of the party to
whom disclosure is made, (b) information acquired by the party to whom the
disclosure is made from other sources, or (c) information in the public domain
or generally available to interested persons or which at a later date passes
into the public domain or becomes available to the party to whom disclosure is
made without any wrongdoing by the party to whom the disclosure is made.

     5.3  Patho and ATNG shall promptly provide each other with information as
to any significant developments in the performance of this Agreement, and shall
promptly

<PAGE>
notify the other if it discovers that any of its representations, warranties and
covenants contained in this Agreement or in any document delivered in connection
with this Agreement was not true and correct in all material respects or became
untrue or incorrect in any material respect.

     5.4  All parties to this Agreement shall take all such action as may be
reasonably necessary and appropriate and shall use their best efforts in order
to consummate the transactions contemplated hereby as promptly as practicable.

                                   ARTICLE VI

                               PROCEDURE EXCHANGE
                               ------------------

     6.1  At the Effective Date, the exchange shall be effected as set forth in
Texas Revised Statutes with common stock certificates of Patho being exchanged
for ATNG common stock certificates as and when submitted to the transfer agent.

                                   ARTICLE VII

                           CONDITIONS PRECEDENT TO THE
                           ---------------------------
                          CONSUMMATION OF THE EXCHANGE
                          ----------------------------

     The following are conditions precedent to the consummation of the Agreement
on or before the Effective Date:

     7.1  ATNG shall have performed and complied with all of its respective
obligations hereunder which are to be complied with or performed on or before
the Effective Date and Patho and ATNG shall provide one another at the Closing
with a certificate to the effect that such party has performed each of the acts
and undertakings required to be performed by it on or before the Closing Date
pursuant to the terms of this Agreement.

     7.2  This Agreement, the transactions contemplated herein shall have been
duly and validly authorized, approved and adopted, at meetings of the
shareholders of ATNG duly and properly called for such purpose in accordance
with the applicable laws.

     7.3  No action, suit or proceeding shall have been instituted or shall have
been threatened before any court or other governmental body or by any public
authority to restrain, enjoin or prohibit the transactions contemplated herein,
or which might subject any of the parties hereto or their directors or officers
to any material liability, fine, forfeiture or penalty on the grounds that the
transactions contemplated hereby, the parties hereto or their directors or
officers, have violated any applicable law or regulation or have otherwise acted
improperly in connection with the transactions contemplated hereby, and the
parties hereto have been advised by counsel that, in the opinion of such
counsel, such action, suit or proceeding raises substantial questions of law or
fact which could reasonably be decided adversely to any party hereto or its
directors or officers.

<PAGE>
     7.4  All actions, proceedings, instruments and documents required to carry
out this Agreement and the transactions contemplated hereby and the form and
substance of all legal proceedings and related matters shall have been approved
by counsel for ATNG and Patho.

     7.5  The representations and warranties made by ATNG and Patho in this
Agreement shall be true as though such representations and warranties had been
made or given on and as of the Effective Date, except to the extent that such
representations and warranties may be untrue on and as of the Effective Date
because of (1) changes caused by transactions suggested or approved in writing
by ATNG or (2) events or changes (which shall not, in the aggregate, have
materially and adversely affected the business, assets, or financial condition
of Patho or ATNG during or arising after the date of this Agreement.)

     7.6  ATNG shall have furnished Patho with:

     (1)  a certified copy of a resolution or resolutions duly adopted by the
Board of Directors of ATNG approving this Agreement and the transactions
contemplated by it and directing the submission thereof to a vote of the
shareholders of ATNG;

     (2)  a certified copy of a resolution or resolutions duly adopted by a
majority of all of the classes of outstanding shares of ATNG capital stock
approving this Agreement and the transactions contemplated by it;

     (3)  an agreement from each "affiliate" of ATNG as defined in the rules
adopted under the Securities Act of 1933, as amended, to the effect that (a) the
affiliate is familiar with SEC Rules 144 and 145; (b) none of the shares of
Patho common stock will be transferred by or through the affiliate in violation
of the Federal Securities Laws; (c) the affiliate will not sell or in any way
reduce his risk relative to any Patho common stock received pursuant to this
Agreement until such time as financial results covering at least 30 days of
post-closing date combined operations shall have been published by Patho on SEC
Form 10-Q or otherwise; and (d) the affiliate acknowledges that Patho is under
no obligation to register the sale, transfer, or the disposition of Patho common
stock by the affiliate or to take any action necessary in order to make an
exemption from registration available to the affiliate, but understands that
Patho will satisfy the public information requirements of Rules 144 and 145
during the three-year period following the Closing Date.

     (4)  Each shareholder of ATNG shall sign an Exchange Agreement as contained
on Schedule A.

     7.7  Patho shall furnish ATNG with a certified copy of a resolution or
resolutions duly adopted by the Board of Directors of Patho, approving this
Agreement and the transactions contemplated by it.

<PAGE>
                                  ARTICLE VIII

                           TERMINATION AND ABANDONMENT
                           ---------------------------

     8.1  Anything contained in this Agreement to the contrary notwithstanding,
the Agreement may be terminated and abandoned at any time (whether before or
after the approval and adoption thereof by the shareholders of ATNG) prior to
the Effective Date:

     (a)  By mutual consent of ATNG and Patho;

     (b)  By ATNG, or Patho, if any condition set forth in Article VII relating
to the other party has not been met or has not been waived;

     (c)  By ATNG, or Patho, if any suit, action or other proceeding shall be
pending or threatened by the federal or a state government before any court or
governmental agency, in which it is sought to restrain, prohibit or otherwise
affect the consummation of the transactions contemplated hereby;

     (d)  By any party, if there is discovered any material error, misstatement
or omission in the representations and warranties of another party;

     (e)  By any party if the Agreement Effective Date is not within 30 days
from the date hereof; or

     (f)  ATNG shall have the right to assign this agreement to any other
entity, at any time, subject to the due diligence terms herein.

     8.2  Any of the terms or conditions of this Agreement may be waived at any
time by the party which is entitled to the benefit thereof, by action taken by
its Board of Directors provided; however, that such action shall be taken only
if, in the judgment of the Board of Directors taking the action, such waiver
will not have a materially adverse effect on the benefits intended under this
Agreement to the party waiving such term or condition.

                                   ARTICLE IX
                       TERMINATION OFF REPRESENTATION AND
                       ----------------------------------
                        WARRANTIES AND CERTAIN AGREEMENTS
                        ---------------------------------

     9.1  The respective representations and warranties of the parties hereto
shall expire with, and be terminated and extinguished by consummation of the
Agreement; provided, however, that the covenants and agreements of the parties
hereto shall survive in accordance with their terms.

                                    ARTICLE X

                                  MISCELLANEOUS
                                  -------------

<PAGE>
     10.1 This Agreement embodies the entire agreement between the parties, and
there have been and are no agreements, representations or warranties among the
parties other than those set forth herein or those provided for herein.

     10.2 To facilitate the execution of this Agreement, any number of
counterparts hereof may be executed, and each such counterpart shall be deemed
to be an original instrument, but all such counterparts together shall
constitute but one instrument. Counterparts shall include the execution of the
Exchange Agreement and Representations by all shareholders.

     10.3 All parties to this Agreement agree that if it becomes necessary or
desirable to execute further instruments or to make such other assurances as are
deemed necessary, the party requested to do so will use its best efforts to
provide such executed instruments or do all things necessary or proper to carry
out the purpose of this Agreement.

     10.4 This Agreement may be amended upon approval of the Board of Directors
of each party provided that the shares issuable hereunder shall not be amended
without approval of the requisite shareholders of ATNG.

     10.5 Any notices, requests, or other communications required or permitted
hereunder shall be delivered personally or sent by overnight courier service,
fees prepaid, addressed as follows:

To ATNG:

     6401 Poplar Avenue, Suite 330
     Memphis, TN 38119

To Pathobiotek Diagnostics Inc.:

     4800 Research Forest Drive
     The Woodlands, TX 77381- 4142

or such other addresses as shall be furnished in writing by any party, and any
such notice or communication shall be deemed to have been given as of the date
received.

     10.6 No press release or public statement will be issued relating to the
transactions contemplated by this Agreement without prior approval of ATNG and
Patho. However, either ATNG or Patho may issue at any time any press release or
other public statement it believes on the advice of its counsel it is obligated
to issue to avoid liability under the law relating to disclosures, but the party
issuing such press release or public statement shall make a reasonable effort to
give the other party prior notice of and opportunity to participate in such
release or statement.

<PAGE>
     IN WITNESS WHEREOF, the parties have set their hands and seals this 24th
                                                                         ----
day of August, 2001.

ATNG, Inc.

By:  /s/ [Signature Unreadable]
     --------------------------
       Director

Attest:/s/ [Signature Unreadable]
       --------------------------
       Director

Pathobiotek Diagnostics Inc.

By:  /s/ [Signature Unreadable]
     --------------------------
       President

Attest:/s/ [Signature Unreadable]
       --------------------------
       Secretary (illegible)

ATNG Acquisition, Inc.

By:  /s/ [Signature Unreadable]
     --------------------------
       President

Attest:/s/ [Signature Unreadable]
       --------------------------
       Secretary (illegible)

<PAGE>SECURITIES MERGER AGREEMENT

	 	 	 	 	 
	
THIS SECURITIES MERGER AGREEMENT ("Agreement") is entered into as of October 15, 2003 by and among Viper Networks, Inc., a Utah corporation ("Viper" or the "Company"), those certain representatives of the Company listed on Exhibit A attached hereto (the "Viper Representatives"), Mid-Atlantic International, Inc., a Michigan corporation ("Mid-Atlantic"), and the sole common stockholder of Mid-Atlantic, Farid Shouekani ("Shouekani") listed on Exhibit B attached hereto.

	 	 	 	 	 
	
R E C I T A L S

	
A.     The Company has authorized capital stock consisting of 100,000,000 shares of common stock ("Common Stock"), no par value, of which 54,000,000 shares are issued and outstanding; 100,000 shares of Class A preferred stock ("Class A Preferred Stock"), with a par value of $1.00 per share, of which no shares are issued and outstanding; and 10,000,000 shares of Class B preferred stock ("Class B Preferred Stock"), with a par value of $1.00 per share, of which 450,000 shares are issued and outstanding.

	
B.     Mid-Atlantic has authorized capital stock consisting of 60,000 shares of common stock, no par value, of which 1,000 shares are issued and outstanding ("Mid-Atlantic Shares") and held by the Shouekani.

	
C.     Shouekani wishes to exchange his 100% non-dilutive ownership of his Mid-Atlantic Shares on the Closing Date (as defined below), for $1,150,000, as follows:  $50,000 cash within 21 days of closing as a sign up bonus; and $1,100,000 in Viper's common stock by issuance of two separate common stock certificates, as follows: (1) 3,300,000 shares of the Company's Common Stock and (2) 4,235,000 shares of the Company's Common Stock (the "Company Common Shares"), both of which will exchanged with Shouekani.  The 4,235,000 shares of the Company's Common Stock with be subject to certain redemption rights, as outlined paragraph 1.2 (b) i.

	
A G R E E M E N T

	 	
It is agreed as follows: 

	 	
1.
	
Securities Purchase And Reorganization

	 	 	
1.1
	
Agreement to Merge and Exchange Securities.  Subject to the terms and upon the conditions set forth herein, Shouekani agrees to assign, transfer and deliver to the Company, and the Company agrees to receive from Shouekani, at the Closing (as defined below), the Mid-Atlantic Shares owned by Shouekani as set forth on Exhibit A attached hereto, in exchange for the transfer, at the Closing, by the Company to Shouekani a pro rata share of the Company Common Shares, as determined according to Section 1.1(a) below.   

	 	 	 	
(a)
	
Determination of Pro Rata Share of Company Common Shares.  The number of Common Company Shares which Shouekani is entitled to receive hereunder will be exchanged pro rata, based on the 1,000 Mid-Atlantic Shares owned by Shouekani at the Closing.  Not withstanding the forgoing pro rata shall mean The exchange ratio of  1 share of Mid Atlantic owned by Shouekani for 7535 of Viper.

	 	 	
1.2
	
Instruments of Transfer.

	 	 	 	
(a)
	
Mid-Atlantic Shares.  Shouekani shall deliver to the Company original certificates evidencing the Mid-Atlantic Shares along with executed stock powers, in form and substance satisfactory to the Company, for purposes of assigning and transferring all of his right, title and interest in and to the Mid-Atlantic Shares.  From time to time after the Closing Date, and without further consideration, Shouekani will execute and deliver such other instruments of transfer and take such other actions as the Company may reasonably request in order to facilitate the transfer to the Company of the securities intended to be transferred hereunder.

	 	 	 	
(b)
	
The Company Common Shares.  The Company shall deliver to Shouekani on the Closing Date two original certificates evidencing the issuance of 3,300,000 and 4,235,000 of the Company Common Shares or in the alternative an authorized Treasury Order to the Company's Transfer Agent for the same, in form and substance satisfactory to Shouekani, in order to effectively vest Shouekani all right, title and interest in and to the Company Common Shares.  The issuance of the 4,235,000 Company Common Shares will be subject to certain redemption rights, as identified in paragraph 1.2 (b) i of this Agreement below.  From time to time after the Closing Date, and without further consideration, the Company will execute and deliver such other instruments and take such other actions as Shouekani may reasonably request in order to facilitate the issuance of the Company Common Shares.

	 	 	 	 	
(i)
	
Redemption Rights.  The 4,235,000 Company Common Shares will be issued, but released pursuant and subject to certain redemption rights held by Shouekani, with terms and conditions, as follows:

	 	
a.
	
Shouekani will have an option to redeem any or all in part or whole of the above-referenced 4,235,000 Company Common Shares to Viper, thereby requiring Viper to redeem these Company Common Shares from Shouekani at a price of $.17 per Company Common Share, prior to close of business on January 15, 2003.  To guarantee the purchase of the above-referenced 4,235,000 Company Common Shares by Viper from Shouekani, the assets listed on Exhibit G of this Agreement will be held as collateral by Shouekani and remain as same.  Should Shouekani not elect to sell any or all of the above-referenced 4,235,000 Company Common Shares to Viper, pursuant to this redemption option, the assets listed on Exhibit G will be released as collateral by Shouekani to Viper and the collateral so secured shall be released.  Should Viper not fulfill its obligation to redeem said Company Common shares, Shouekani will be entitled to the collateral listed on Exhibit G and simultaneously turnover said Company Common Shares back to Viper to be cancelled and returned to treasury.

	 	
b.
	
Viper shall have the redemption obligation to reacquire all of the unredeemed amount of all the 4,235,000 shares in Viper so originally issued to Shouekani at a price of $0.17 per Company Common Share, prior to close of business day on January 15, 2004, or in the option of Shouekani to hold the company in default of this entire agreement.

	 	
c.
	
The assets of Mid-Atlantic to be held as collateral shall be listed and made subject to a Purchase Money Security Agreement and UCC-1 Financing Statement filing in both the State of Michigan and State of California and in each political subdivision or county where said assets are maintained.

	 	 	
1.3
	
Closing.  The closing ("Closing") of the exchange of the Mid-Atlantic Shares and the Company Common Shares shall take place at the offices of the Company at 12:00 p.m., local time, on October 15, 2003, or at such other time and place as may be agreed to by all of the parties hereto ("Closing Date").

	 	 	
1.4
	
Tax Free Reorganization.  The parties intend that the transaction under this Agreement qualify as a tax free reorganization under Section 368 (a)(1)(B) of the Internal Revenue Code of 1986, as amended.

	 	 	
1.5
	
Merger Date.  The merger shall be finalized on January 15, 2004 or earlier upon all of company's (Viper) covenants being fulfilled, at which time, Shouekani shall file form 550M with the Michigan Corporate & Securities (C&S) division evidencing the merger.     

	 	
2.
	
Deliveries At Closing.

	 	 	
2.1
	
Company's Deliveries at Closing.  At or prior to the Closing, the Company shall deliver or cause to be delivered to Shouekani all of the following:

	 	 	 	
(a)
	
Certificates or Treasury Order in form acceptable to Shouekani representing the Company Common Shares, registered in the names of the Shouekani; and a check payable to Shouekani in the amount of Fifty Thousand ($50,000.00) Dollars drawn upon Viper's general account signed by its president or other duly authorized officer on post dated twenty one (21) days from the date of this execution hereof. 

	 	 	 	
(b)
	
An Officer's Certificate signed by the Company's president in the form attached hereto as Exhibit C; 

	 	 	 	
(c)
	
Certified resolutions of the Board of Directors of the Company in the form attached hereto as Exhibit D (i) authorizing the consummation of the transactions contemplated by this Agreement; and (ii) electing the persons designated as officers and directors of the Company and Mid-Atlantic effective as of the Closing Date.

	 	 	 	
(d)
	
A certificate of good standing of the Company from the State of Utah as of the most recent practicable date.

	 	 	 	
(e)
	
Such other documents and instruments as shall be reasonably necessary to effect the transactions contemplated hereby, including the aforementioned Purchase Money Security Agreement and UCC-1 Registrations. 

	 	 	
2.2
	
Shouekani's Deliveries at Closing.  At or prior to the Closing, the Merging Stockholders shall deliver or cause to be delivered to the Company all of the following:

	 	 	 	
(a)
	
Original certificates representing the Mid-Atlantic Shares, along with duly executed stock powers, in form and substance satisfactory to the Company.

	 	 	 	
(b)
	
Such other documents and instruments as shall be reasonably necessary to effect the transactions contemplated hereby.

	 	 	
2.3
	
Mid-Atlantic's Deliveries at Closing.  At or prior to the Closing, Mid-Atlantic shall deliver or cause to be delivered to the Company all of the following:

	 	 	 	
(a)
	
An Officer's Certificate signed by Mid-Atlantic's president in the form attached hereto as Exhibit E.

	 	 	 	
(b)
	
Certified resolutions of the Board of Directors of Mid-Atlantic in the form attached hereto as Exhibit F authorizing the consummation of the transactions contemplated by this Agreement.

	 	 	 	
(c)
	
A certificate of good standing of Mid-Atlantic from the State of Michigan as of the most recent practicable date.

	 	 	 	
(d)
	
Such other documents and instruments as shall be reasonably necessary to effect the transactions contemplated hereby.

	 	
3.
	
Representations and Warranties of Shouekani.  Shouekani severally represents, warrants and covenants to and with the Company with respect to himself, as follows:

	 	 	
3.1
	
Power and Authority.  Shouekani has all requisite individual power and authority to enter into and to carry out all of the terms of this Agreement and all other documents executed and delivered in connection herewith (collectively, the "Documents").  All individual action on the part of Shouekani necessary for the authorization, execution, delivery and performance of the Documents by Shouekani has been taken and no further authorization on the part of Shouekani is required to consummate the transactions provided for in the Documents.  When executed and delivered by Shouekani, the Documents shall constitute the valid and legally binding obligation of Shouekani enforceable in accordance with their respective terms, except as limited by applicable bankruptcy, insolvency reorganization and moratorium laws and other laws affecting enforcement of creditor's rights generally and by general principles of equity.

	 	 	
3.2
	
Ownership of and Title to Securities.  Shouekani represents that he is the sole owner of the Mid-Atlantic Shares held by him and that there are no warrants, options, subscriptions, calls, or other similar rights of any kind for the issuance or purchase of any of the Mid-Atlantic Shares or other securities of Mid-Atlantic held by Shouekani. Shouekani represents that he will transfer to the Company good and marketable title to the Mid-Atlantic Shares which he owns, free and clear of all pledges, security interests, mortgages, liens, claims, charges, restrictions or encumbrances.

	 	 	
3.3
	
Investment and Related Representations.  Shouekani is aware that neither the Company Common Shares nor the offer or sale thereof to Shouekani has been registered under the Securities Act of 1933, as amended ("Act"), or under any state securities law.  Shouekani understands that the Company Common Shares will be characterized as "restricted" securities under federal securities laws inasmuch as they are being acquired in a transaction not involving a public offering and that under such laws and applicable regulations such securities may be resold without registration under the Act only in certain limited circumstances.  Shouekani agrees that he will not sell all or any portion of the Company Shares except pursuant to registration under the Act or pursuant to an available exemption from registration under the Act.  The Selling Stockholder understands and acknowledges that all certificates representing the Company Shares shall bear the following legend or a legend of similar import and that the Company shall refuse to transfer the Company Shares except in accordance with such restrictions:

	
"THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR UNDER CERTAIN STATE SECURITIES LAWS.  NO SALE OR TRANSFER OF THESE SHARES MAY BE MADE IN THE ABSENCE OF (1) AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR (2) AN OPINION OF COUNSEL THAT REGISTRATION UNDER THE ACT OR UNDER APPLICABLE STATE SECURITIES LAWS IS NOT REQUIRED IN CONNECTION WITH SUCH PROPOSED SALE OR TRANSFER."

	
Not withstanding the forgoing, on or before Jan 15, 2004, company shall cause Shouekani's 3,300,000 common shares in company to be registered and available for sale as permitted under the "ACT".  Those shares shall also participate in any reverse or forward splits authorized by the board of directors of Company that occur between the date of execution here of and the date of the said shares being registered so as to cause no dilution of this shares value. 

	 	
4.
	
Representations And Warranties Of Mid-Atlantic.  Mid-Atlantic represents, warrants and covenants to and with the Company as follows:

	 	 	
4.1
	
Organization and Good Standing.  Mid-Atlantic is a corporation duly organized, validly existing, and in good standing under the laws of the State of Michigan and has full corporate power and authority to enter into and perform its obligations under this Agreement.

	 	 	
4.2
	
Capitalization.  The authorized capital stock of Mid-Atlantic consists of 60,000 shares of common stock, no par value, of which 1,000 shares are issued and outstanding. All outstanding shares of Mid-Atlantic's common stock were issued in compliance with applicable state of Michigan laws, have been duly authorized and validly issued, and are fully paid, nonassessable, and free of any preemptive rights.  There are no warrants, options, subscriptions, calls, other similar rights to purchase any of Mid-Atlantic's capital stock, and there are no voting, pooling or voting trust agreements, arrangements or contracts by and among Mid-Atlantic, its shareholders, or any of them.

	 	 	
4.3
	
Validity of Transactions.  This Agreement, and each document executed and delivered by Mid-Atlantic in connection with the transactions contemplated by this Agreement, and the performance of the transactions contemplated therein have been duly authorized by the directors of Mid-Atlantic, have been duly executed and delivered by Mid-Atlantic and is each the valid and legally binding obligation of Mid-Atlantic, enforceable in accordance with its terms, except as limited by applicable bankruptcy, insolvency reorganization and moratorium laws and other laws affecting enforcement of creditor's rights generally and by general principles of equity.  

	 	 	
4.4
	
No Conflict.  The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby do not and will not conflict with, or result in a breach of any term or provision of, or constitute a default under or result in a violation of (i) the Certificate of Incorporation or Bylaws of Mid-Atlantic, as amended, (ii) any agreement, contract, lease, license or instrument to which Mid-Atlantic is a party or by which Mid-Atlantic or any of its properties or assets are bound, or (iii) any judgment, decree, order, or writ by which Mid-Atlantic is bound or to which it or any of its properties or assets are subject.

	 	 	
4.5
	
Approvals and Consents.  There are no permits, consents, mandates or approvals of public authorities, either federal, state or local, or of any third party necessary for Mid-Atlantic's consummation of the transactions contemplated hereby.

	 	 	
4.6
	
Accuracy of Information.  None of the representations or warranties or information provided and to be provided by the Mid-Atlantic in this Agreement, or any schedules or exhibits hereto, contains or will contain any untrue statement of a material fact or omits or will omit to state any material facts necessary in order to make the statements and facts contained herein or therein not false or misleading.  Copies of all documents heretofore or hereafter delivered or made available to Mid-Atlantic pursuant hereto were or will be complete and accurate records of such documents.

	 	
5.
	
Representations, Warranties and Covenants of the Company.  The Company represents, warrants and covenants to and with Mid-Atlantic and Shouekani the items listed on the "Company Disclosure Schedule".  As used herein, the term "Company Disclosure Schedule" shall refer to the Company Disclosure Schedule attached hereto.

	 	 	
5.1
	
Organization and Good Standing.  The Company is a corporation duly organized, validly existing, and in good standing under the laws of the State of Utah and has full corporate power and authority to enter into and perform its obligations under this Agreement.

	 	 	
5.2
	
Capitalization. The Company has authorized capital stock consisting of 100,000,000 shares of common stock ("Common Stock"), no par value, of which 54,000,000 shares are issued and outstanding; 100,000 shares of Class A preferred stock ("Class A Preferred Stock"), with a par value of $1.00 per share, of which no shares are issued and outstanding; and 10,000,000 shares of Class B preferred stock ("Class B Preferred Stock"), with a par value of $1.00 per share, of which 450,000 shares are issued and outstanding.

	 	 	
5.3
	
Validity of Transactions.  Except as set forth on the Company Disclosure Schedule: (i) this Agreement, and each document executed and delivered by the Company in connection with the transactions contemplated by this Agreement, and the performance of the transactions contemplated therein have been duly authorized by the directors of the Company, have been duly executed and delivered by the Company and is each the valid and legally binding obligation of the Company, enforceable in accordance with its terms, except as limited by applicable bankruptcy, insolvency reorganization and moratorium laws and other laws affecting enforcement of creditor's rights generally and by general principles of equity; (ii) the Company Shares issuable hereunder, when issued in accordance with the terms of this Agreement, will be duly authorized, validly issued, fully paid and nonassessable; and (iii) the Company Common Shares will be free of any liens or encumbrances, except for any restrictions imposed by federal or state securities laws.

	 	 	
5.4
	
No Conflict.  Except as set forth on the Company Disclosure Schedule, the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby do not and will not conflict with, or result in a breach of any term or provision of, or constitute a default under or result in a violation of (i) the Articles of Incorporation or Bylaws of the Company, as amended, (ii) any agreement, contract, lease, license or instrument to which the Company is a party or by which the Company or any of its properties or assets are bound, or (iii) any judgment, decree, order, or writ by which the Company is bound or to which it or any of its properties or assets are subject.

	 	 	
5.5
	
Approvals and Consents.  Except as set forth on the Company Disclosure Schedule, there are no permits, consents, mandates or approvals of public authorities, either federal, state or local, or of any third party necessary for the Company's consummation of the transactions contemplated hereby.

	 	 	
5.6
	
Litigation.  Except as set forth in the Company Disclosure Schedule, there are no suits or proceedings (including without limitation, proceedings by or before any arbitrator, government commission, board, bureau or other administrative agency) pending or, to the knowledge of the Company, threatened against or affecting the Company, the officers or directors of the Company or any of their respective affiliates or which questions or threatens the validity of this Agreement or any action to be taken in connection therewith, and neither the Company nor any of its assets is subject to or in default with respect to any order, writ, injunction or decree of any federal, state, local or other governmental department.  The Company has not commenced and does not currently intend to commence any legal proceedings against any other person or entity.

	 	 	
5.7
	
Taxes.  All federal income tax returns and state and local income tax returns for the Company have been filed as required by law.  All taxes as shown on such returns or on any assessment received subsequent to the filing of such returns have been paid, and there are no pending assessments or adjustments or any income tax payable for which reserves, which are reasonably believed by the Company to be adequate for the payment of any additional taxes that may come due, have not been established.  All other taxes imposed by any government authority on the Company have been paid and any reports or returns due in connection therewith have been filed.  No outstanding claim for assessment or collection of taxes has been asserted against the Company and there are no pending, or to the knowledge of the Company, threatened tax audits, examinations or claims.

	 	 	
5.8
	
No Defaults.  No material default (or event which, with the passage of time or the giving of notice, or both, would become a material default) exists or is alleged to exist with respect to the performance of any obligation either of the Company under the terms of any indenture, license, mortgage, deed of trust, lease, note, guaranty, joint venture agreement, operating agreement, partnership agreement, or other contract or instrument to which the Company is a party or any of its assets are subject, or by which it is otherwise bound, and, to the best knowledge of the Company, no such default or event exists or is alleged to exist with respect to the performance of any obligation of any party thereto.

	 	 	
5.9
	
Corporate Documents.  The Company has furnished to Mid-Atlantic and the Merging Stockholders true and complete copies of the Articles of Incorporation and Bylaws of the Company certified by its secretary and copies of the resolutions adopted by the Company's Board of Directors authorizing and approving this Agreement and the transactions contemplated hereby.  The Company has made available to Mid-Atlantic and Shouekani and their representatives all corporate minute books of the Company, and such minute books contain complete and accurate records of the proceedings of the Company's shareholders and directors.

	 	 	
5.10
	
Contracts and Other Commitments.  Except as set forth on the Company Disclosure Schedule, the Company does not have and is not bound by any contract, agreement, lease, commitment or proposed transaction, judgment, order, writ or decree, written or oral, absolute or contingent.

	 	 	
5.11
	
Compliance with Laws.  The Company has complied in all material respects with all laws, regulations and orders affecting its business and operations and is not in default under or in violation of any provision of any federal, state or local rule, regulation or law, including without limitation, any applicable statute, law or regulation relating to the environment or occupational health and safety, and no material expenditures are or will be required in order to comply with any such existing statute, law or regulation.

	 	 	
5.12
	
Assets or Liabilities.  Except as set forth on the Company Disclosure Schedule or the Company's financial statements dated June 1, 2003, the Company represents and warrants that it does not have any assets, liabilities or operations.

	 	 	
5.13
	
Absence of Certain Changes.   Except as set forth on the Company Disclosure Schedule, since the date of the Company's financial statements dated December 31, 2002, there has not been any Material Adverse Change or any change of the kind described in Section 7.4 of this Agreement.  For the purposes hereof, "Material Adverse Change" means any event, circumstance, condition, development or occurrence causing, resulting in, having or that could reasonably be expected to have, a material adverse effect on the business, assets or financial condition of the Company.

	 	 	
5.14
	
Brokers and Finders.  The Company has not dealt with any broker or finder in connection with the transactions contemplated hereby.  The Company has not incurred, nor shall it incur, directly or indirectly, any liability for any brokerage or finders' fees, agent commissions or any similar charges in connection with this Agreement or any transaction contemplated hereby.

	 	 	
5.15
	
Intercompany and Affiliate Transactions; Insider Interests.  Except as set forth on the Company Disclosure Schedule, there are, and during the last two years there have been, no transactions, agreements or arrangements of any kind, direct or indirect, between the Company and any director, officer, employee, stockholder, or affiliate of the Company, including, without limitation, loans, guarantees or pledges to, by or for the Company or from, to, by or for any of such persons, that are currently in effect.

	 	 	
5.16
	
Accuracy of Information.  None of the representations or warranties or information provided and to be provided by the Company to Mid-Atlantic or the Merging Stockholders in this Agreement, or any schedules or exhibits hereto, contains or will contain any untrue statement of a material fact or omits or will omit to state any material facts necessary in order to make the statements and facts contained herein or therein not false or misleading.  Copies of all documents heretofore or hereafter delivered or made available to Mid-Atlantic pursuant hereto were or will be complete and accurate records of such documents.

	 	
6.
	
Viper Representatives' Lock-up.  

	 	 	
6.1
	
Lock-Up of Shares.  No lock up agreements.

	 	
7.
	
Additional Understandings and Agreements of the Parties

	 	 	
7.1
	
Access to Mid-Atlantic.  Mid-Atlantic shall afford to the Company and shall cause its independent accountants to afford to the Company, and its accountants, counsel and other representatives, reasonable access during normal business hours during the period prior to the Closing Date to all of Mid-Atlantic's properties, books, contracts, commitments and records and to the audit work papers and other records of Mid-Atlantic's independent accountants.  During such period, Mid-Atlantic shall use reasonable efforts to furnish promptly to the Company all information concerning the business, properties and personnel of Mid-Atlantic as the Company may reasonably request, provided that Mid-Atlantic shall not be required to disclose any information which it is legally required to keep confidential.  The Company will not use such information for purposes other than this Agreement and the transaction contemplated hereby and will otherwise hold such information in confidence (and the Company will cause its consultants and advisors also to hold such information in confidence) until such time as such information otherwise becomes publicly available, and in the event of termination of this Agreement for any reason the Company shall promptly return, or cause to be returned, to Mid-Atlantic all documents obtained from Mid-Atlantic, and any copies made of such documents, extracts and copies thereof.

	 	 	
7.2
	
Access to Company.  The Company shall afford to Mid-Atlantic and Shouekani and shall cause its independent accountants to afford to Mid-Atlantic and Shouekani, and their accountants, counsel and other representatives, reasonable access during normal business hours during the period prior to the Closing Date to all of the Company's properties, books, contracts, commitments and records and to the audit work papers and other records of the Company's independent accountants.  During such period, the Company shall use reasonable efforts to furnish promptly to Mid-Atlantic or the Shouekani such information concerning the Company as Mid-Atlantic or Shouekani may reasonably request, provided that the Company shall not be required to disclose any information which it is legally required to keep confidential.  Mid-Atlantic and Shouekani will not use such information for purposes other than this Agreement and the transaction contemplated hereby and will otherwise hold such information in confidence (and Mid-Atlantic and Shouekani will cause their respective consultants and advisors also to hold such information in confidence) until such time as such information otherwise becomes publicly available, and in the event of termination of this Agreement for any reason Mid-Atlantic and the Shouekani shall promptly return, or cause to be returned, to the Company all documents obtained from the Company, and any copies made of such documents, extracts and copies thereof.

	 	 	
7.3
	
Name Change.  To be determined.

	 	 	
7.4
	
Operation of the Company Prior to Closing.  During the period from the date of this Agreement until the Closing, the Company shall not, except as contemplated, permitted or required by this Agreement, (i) conduct any business or engage in any activities other than activities related to the closing of the transactions contemplated by this Agreement; (ii) declare or pay any dividends on or make any other distributions in respect of any of its capital stock; (iii) split, combine or reclassify any of its capital stock or issue or authorize the issuance of any other securities in respect of, in lieu or, or in substitution for shares of capital stock of the Company except as called for under this Agreement; (iii) repurchase or otherwise acquire any shares of its capital stock or rights to acquire any shares of its capital stock; (iv) issue, deliver or sell or authorize or propose the issuance, delivery or sale of, any shares or its capital stock or any class or securities convertible into, or rights, warrants or options to acquire, any such shares or other convertible securities, except for the issuance and sale of the Company Shares in accordance with the provisions of this Agreement; (v) become a party to or become bound by or agree to become a party to or become bound by any contract, instrument, lease, license, agreement, commitment or undertaking; or (vi) incur or agree to incur any amount of long or short-term debt for money borrowed, or indemnify or agree to indemnify others, or incur or agree to incur any debts, obligations or liabilities whatsoever.

	 	 	
7.5
	
Operation of Acquired Company after close.  After the acquisition of Mid Atlantic as a subsidiary of Viper, Shouekani shall become President and chief financial officer of said subsidiary; and, shall have full and final control over the payment of this obligation of the subsidiary including advancements mad by Shouekani to the acquired company.  These payments shall be deemed contractual bonuses to Shouekani and shall end at the earlier of company's default, merger or 1-15-2004.  Said contractual bonuses shall be disclosed as item 2 at Mid Atlantic's company Discloser immediately flowing the signatory page. 

	 	
8.
	
Conditions Precedent

	 	 	
8.1
	
Conditions to Each Party's Obligations.  The respective obligations of each party to consummate the transactions contemplated by this Agreement shall be subject to the satisfaction on or prior to the Closing of the following conditions unless waived by such party:

	 	 	 	
(a)
	
Government Approvals.  All authorizations, consents, orders or approvals of, or declarations or filings with, or expiration of waiting periods imposed by, any governmental authority necessary for the consummation of the transactions contemplated by this Agreement shall have been filed, occurred or been obtained.

	 	 	 	
(b)
	
Third-Party Approvals.  Any and all consents or approvals required from third parties relating to contracts, licenses, leases and other instruments, material to the respective businesses of the Company and Mid-Atlantic, shall have been obtained.

	 	 	 	
(c)
	
Legal Action.  No temporary restraining order, preliminary injunction or permanent injunction or other order preventing the consummation of the transactions contemplated by this Agreement shall have been issued by any federal or state court and remain in effect, and no litigation seeking the issuance of such an order or injunction, shall be pending which, in the good faith judgment of Mid-Atlantic or the Company, has a reasonable probability of resulting in such order, injunction or damages.  In the event any such order or injunction shall have been issued, each party agrees to use its reasonable efforts to have any such injunction lifted.

	 	 	
8.2
	
Conditions to Obligations of the Company.  The obligations of the Company to consummate the transactions contemplated by this Agreement are subject to the satisfaction on or prior to the Closing of the following conditions, unless waived by the Company:

	 	 	 	
(a)
	
Representations and Warranties of Shouekani.  The representations and warranties of Shouekani set forth in this Agreement shall be true and correct in all material respects as of the date of this Agreement and as if made at and as of the Closing Date, except as otherwise contemplated by this Agreement.

	 	 	 	
(b)
	
Representations and Warranties of Mid-Atlantic.  The representations and warranties of Mid-Atlantic set forth in this Agreement shall be true and correct in all material respects as of the date of this Agreement and as if made at and as of the Closing Date, and the Company shall have received a certificate to such effect signed by the president of Mid-Atlantic.

	 	 	 	
(c)
	
Performance of Obligations of Mid-Atlantic.  Mid-Atlantic shall have performed in all material respects all obligations required to be performed by it under this Agreement prior to the Closing Date, and the Company shall have received a certificate to such effect signed by the president of Mid-Atlantic.

	 	 	 	
(d)
	
Additional Closing Documents.  The Company shall have received (i) each of the documents or instruments listed in Section 2.2 hereof from the Shouekani; (ii) each of the documents or instruments listed in Section 2.3 hereof from Mid-Atlantic; and (iii) such other documents and instruments as are required to be delivered pursuant to the provisions of this Agreement or as otherwise reasonably requested by the Company.

	 	 	
8.3
	
Conditions to Obligations of Mid-Atlantic and Shouekani.  The obligations of Mid-Atlantic and the Shouekani to consummate the transactions contemplated by this Agreement are subject to the satisfaction on or prior to the Closing Date of the following conditions unless waived by Mid-Atlantic and Shouekani:

	 	 	 	
(a)
	
Representations and Warranties.  The representations and warranties of the Company set forth in this Agreement shall be true and correct in all material respects as of the date of this Agreement and as if made at and as of the Closing Date, except as otherwise contemplated by this Agreement, and Mid-Atlantic and Shouekani shall have received a certificate to such effect signed by the President of the Company.

	 	 	 	
(b)
	
Performance of Obligations of the Company.  The Company shall have performed in all material respects all obligations required to be performed by it under this Agreement prior to the Closing Date, and Mid-Atlantic shall have received a certificate to such effect signed by the president of the Company.

	 	 	 	
(c)
	
Additional Closing Documents.  Mid-Atlantic and Shouekani shall have received (i) the documents and instruments referenced in Section 2.1 hereof; and (ii) such other documents and instruments as are required to be delivered pursuant to the provisions of this Agreement or otherwise reasonably requested by Mid-Atlantic.

	 	
9.
	
Miscellaneous.

	 	 	
9.1
	
Cumulative Remedies.  Any person having any rights under any provision of this Agreement will be entitled to enforce such rights specifically, to recover damages by reason of any breach of any provision of this Agreement, and to exercise all other rights granted by law, which rights may be exercised cumulatively and not alternatively.

	 	 	
9.2
	
Successors and Assigns.  Except as otherwise expressly provided herein, this Agreement and any of the rights, interests or obligations hereunder may not be assigned by any of the parties hereto. All covenants and agreements contained in this Agreement by or on behalf of any of the parties hereto will bind and inure to the benefit of the respective permitted successors and assigns of the parties hereto whether so expressed or not.

	 	 	
9.3
	
Severability.  Whenever possible, each provision of this Agreement will be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision will be ineffective only to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement or the other documents.

	 	 	
9.4
	
Counterparts.  This Agreement may be executed in two or more counterparts, any one of which need not contain the signatures of more than one party, but all such counterparts when taken together will constitute one and the same agreement.

	 	 	
9.5
	
Entire Agreement.  This Agreement constitutes the entire agreement and understanding of the parties with respect to the subject matter thereof, and supersedes all prior and contemporaneous agreements and understandings.

	 	 	
9.6
	
Survival of Representations.  All representations, warranties and agreements contained herein or made in writing by the Company, Mid-Atlantic and Shouekani in connection with the transactions contemplated hereby except any representation, warranty or agreement as to which compliance may have been appropriately waived, shall survive the execution and delivery of this Agreement.

	 	 	
9.7
	
Expenses and Attorney Fees.  The Company, Mid-Atlantic and Shouekani shall each pay all of their respective legal and due diligence expenses in connection with the transactions contemplated by this Agreement, including, without limiting the generality of the foregoing, legal and accounting fees.

	 	 	 	
Should any controversy arises regarding the terms and conditions of this agreement such controversy shall be submitted to arbitration, which shall be binding upon the parties and a Circuit Court of competent jurisdiction located in the state of Michigan and whose empanelment shall be constituted of one (1) arbitrator of Viper's/Mid Atlantic choosing; one(1) of Farid Shouekani's choosing and one(1) agreed to by chosen panel. The majority vote of the ensuing panel regarding its ultimate determination of the dispute resolution and damages, if any, shall be final, binding and submitted to sad Court for its Final Order.  This proceeding shall be and follow in accordance with and under the preview of the American Arbitration Association located in Southfield Michigan.

	 	 	
9.8
	
Waiver of Conditions.  At any time or times during the term hereof, the Company may waive fulfillment of any one or more of the conditions to its obligations in whole or in part, and Mid-Atlantic or Shouekani may waive fulfillment of any one or more of the foregoing conditions to their obligation, in whole or in part, by delivering to the other party a written waiver or waivers of fulfillment thereof to the extent specified in such written waiver or waivers.  Any such waiver shall be validly and sufficiently authorized for the purposes of this Agreement if, as to any party, it is authorized in writing by an authorized representative of such party.  The failure of any party hereto to enforce at any time any provision of this Agreement shall not be construed to be a waiver of such provision, nor in any way to affect the validity of this Agreement or any part hereof or the right of any party thereafter to enforce each and every such provision.  No waiver of any breach of this Agreement shall be held to constitute a waiver of any other or subsequent breach.

	 	 	
9.9
	
Law Governing.  This Agreement shall be construed and interpreted in accordance with and governed and enforced in all respects by the laws of the State of Michigan.

	 	 	
9.10
	
Attorneys' Fees.  If any action at law or in equity is necessary to enforce or interpret the terms of this Agreement, the prevailing party shall be entitled to reasonable attorneys' fees, costs and disbursements in addition to any other relief to which such party may be entitled.

	 	 	
9.11
	
Delivery by Fax.  Delivery of an executed counterpart of the Agreement or any exhibit attached hereto by facsimile transmission shall be equally as effective as delivery of an executed hard copy of the same.  Any party delivering an executed counterpart of this Agreement or any exhibit attached hereto by facsimile transmission shall also deliver an executed hard copy of the same, but the failure by such party to deliver such executed hard copy shall not affect the validity, enforceability or binding nature effect of this Agreement or such exhibit.  

	 	 	
9.12
	
Gender Neutral Pronouns.  All pronouns and any variations thereof shall be deemed to refer to the masculine, feminine or neuter, singular or plural, as the identity of the referenced person, persons, entity or entities may require.

	 	 	
9.13
	
Indemnification and Hold Harmless.  Viper, Mid Atlantic and the subsidiary's current board of directors of each jointly, severable and individually agree to indemnify and hold harmless Farid Shouekani, his heirs, successors and assigns, from any and all liability arising our of this merger of Mid Atlantic into Viper and arising our of any and all Security Exchange Commission violations or any other violation of any other board of common securities exchange or of any state corporations and securities laws, including those laws of the state of Utah that may have arisen due to this consummation of this transaction.  Should litigation arise, 9.7 of this agreement shall control.

	
 
	 	 	 	 
	
[THIS SPACE INTENTIONALLY LEFT BLANK]

	
 
	 	 	 	 
	
          IN WITNESS WHEREOF, each of the parties to this Agreement has executed or caused this Agreement to be executed as of the date first above written.

	 	 	 	 	 
	
"COMPANY"

Viper Networks, Inc

a Utah corporation
	
"VIPER REPRESENTATIVES"

Signatures Appear on Exhibit A

	
By:                              

     Stephen Young, President
	 
	
 
	 
	
"MID-ATLANTIC"

Mid-Atlantic International, Inc.

a Michigan corporation
	
"MERGING STOCKHOLDERS"

Signatures Appear on Exhibit B

	
By:                              

     Farid Shouekani, President
	 
	
 
	 	 	 	 
	
 
	 	 	 	 
	
COMPANY DISCLOSURE SCHEDULE

	 	 	 	 	 
	
          The following schedule is intended to provide Mid-Atlantic International, Inc. and Farid Shouekani with additional disclosure regarding the company and must be read in conjunction Section 5 of the SECURITIES MERGER AGREEMENT. 

	 	
1.
	
Section 5.12.  The last audited financial statements of Company or as of December 31, 2000.  The last unaudited balance sheet is as of June 30, 2003.  Copies of both have been provided Mid-Atlantic.

	
 
	 	 	 	 
	
 
	 	 	 	 
	
EXHIBIT A

	
Viper Representatives

	
                                    
	 	 
	
Name and Address 

of Viper Representative
	
Signature
	
Number of Securities

	
John Castiglione
	
_______________________
	
6,000,000 shares of common

	
Jason Sunstein
	
_______________________
	
6,000,000 shares of common

	
Stephen Young
	
_______________________
	
6,000,000 shares of common

	
Ronald Weaver
	
_______________________
	
6,000,000 shares of common

	
Jason Sunstein, Secretary

Viper Networks, Inc.

Employee Compensation Fund
	
_______________________
	
10,000,000 shares of common

	
 
	 	 	 	 
	
 
	 	 	 	 
	
EXHIBIT B

	
LIST OF MERGING STOCKHOLDERS

	 
	
Name and Address of Selling Stockholder
	
Signature
	
Number of 

MID-ATLANTIC Shares 
	
Number of Common Company Shares
	 
	
	
	
	
	

	
Farid Shouekani

421 Mayapple Ct.

Rochester, MI  

48307
	
_______________
	
1,000
	
3,300,000

4,235,000*
	 
	
                             
	
_______________
	 	 	 
	
 
	 	 	 	 
	
*Subject to certain put and call options, as identified in Paragraph 1.2 (b) i herein.

	
*In addition to the $50,000 cash sign up bonus, as stated in Paragraph C on Page 1.

	
 
	 	 	 	 
	
 
	 	 	 	 
	
EXHIBIT C

	
 
	 	 	 	 
	
FORM OF COMPANY OFFICERS CERTIFICATE

	
 
	 	 	 	 
	
          The undersigned hereby certifies to Mid-Atlantic and the Merging Stockholders (as those terms are defined in that certain SECURITIES MERGER AGREEMENT dated as of October 10, 2003 by and among Mid-Atlantic, Farid Shouekani, Viper Networks, Inc. and the Viper Representatives (the "Agreement")) that:

	 	
1.
	
I am the duly elected and acting President of Viper Networks, Inc., a Utah corporation ("Company").

	 	
2.
	
This Officer's Certificate is being delivered to Mid-Atlantic and Farid Shouekani pursuant to Sections 2.1(b) and 8.3(a) of the Agreement.

	 	
3.
	
All of the representations and warranties of the Company made in the Agreement are true and correct in all material respects on and as of the date hereof as though such representations and warranties had been made or given on and as of the date hereof.

	 	
4.
	
The Company has performed and complied in all material respects with all of the covenants and agreements made in the Agreement to be performed by or complied with by the Company on or prior to the date hereof.

	
          Executed effective as of October 10, 2003.

	
 
	 	 	 	 
	 	 	 	 	
          __________________________________________

          Stephen Young, President

	
 
	 	 	 	 
	
 
	 	 	 	 
	
EXHIBIT D

	
 
	 	 	 	 
	
FORM OF COMPANY RESOLUTIONS

	
 
	 	 	 	 
	
UNANIMOUS WRITTEN CONSENT

OF THE BOARD OF DIRECTORS OF

VIPER NETWORKS, INC.

A Utah Corporation

	
 
	 	 	 	 
	
          The undersigned, being all of the directors of Viper Networks, Inc., Inc., a Utah corporation (the "Corporation"), hereby adopt the following recitals and resolutions by their unanimous written consent thereto, effective as of October 10, 2003, hereby waiving all notice of and the holding of any meeting of the board of directors to act upon such resolutions.

	
SECURITIES MERGER AGREEMENT

	
          WHEREAS, there has been presented to the board of directors of this Corporation a proposed SECURITIES MERGER AGREEMENT (the "Agreement") by and among this Corporation, Mid-Atlantic Communications, Inc., a California corporation ("Mid-Atlantic"), and the sold common stockholder of Mid-Atlantic, Farid Shouekani ("Shouekani") providing for the exchange by the Corporation of a non-dilutive 100% interest in Mid-Atlantic in exchange for $1,150,000, as follows:  $50,000 cash within 21 days of closing; and $1,100,000 in Buyer's common stock by issuance of two separate common stock certificates, as follows: (1) 3,300,000 shares of the Company's Common Stock and (2) 4,235,000 shares of the Company's Common Stock (the "Company Common Shares"), both of which will exchanged with Shouekani.  The 4,235,000 shares of the Company's Common Stock with have put and call options, as outlined paragraph 1.2 (b) i; and

	
          WHEREAS, the board of directors of this Corporation deems it to be in the best interests of the Corporation and its stockholders that the Corporation acquire a non-dilutive 100% interest in Mid-Atlantic in accordance with the terms and conditions of the Agreement.

	
          RESOLVED, that the form, terms and conditions of the Agreement, as presented to the board of directors, be and they hereby are, in all respects, approved and adopted;

	
          RESOLVED, FURTHER, that the President of this Corporation is hereby authorized and directed, for and on behalf of the Corporation, to execute and deliver the Agreement to Mid-Atlantic and Shouekani with such changes thereto as such officer, in his discretion, deems necessary or desirable;

	
          RESOLVED, FURTHER, that the officers of the Corporation are further authorized and empowered to execute any other agreements or documents and take any further action necessary in order to enable the Corporation to perform its obligations under the Agreement;

	
          RESOLVED, FURTHER, that the officers of the Corporation are further authorized and empowered for and on behalf of the Corporation to issue an aggregate of 6,470,000 shares of Common Stock, as identified in Paragraph 1.2 (b) i, herein;

	
          RESOLVED, FURTHER, that the officers of the Corporation are further authorized and empowered for and on behalf of the Corporation to pay all of the fees and expenses incurred by the Corporation in connection with the negotiation and consummation of the transactions contemplated by the Agreement;

	
          RESOLVED, FURTHER, that the officers of the Corporation are further authorized and empowered for and on behalf of the Corporation to prepare or cause to be prepared, execute and file the appropriate notice and exemption forms pertaining to the issuance of the Corporation's stock pursuant to the Agreement as required under applicable federal and state securities laws including, but not limited to, Form D pursuant to and in accordance with Regulation D of the Securities Act of 1933.

	
ELECTION OF DIRECTOR

	
          RESOLVED, that pursuant to the power conferred on the board of directors of the Corporation by the Corporation's Bylaws, subject to the Agreement and the closing of the transactions contemplated thereby, the board of directors of the Corporation hereby determines that the exact number of authorized directors of the Corporation shall be five (5), effective immediately until such time as the number is changed in accordance with the Corporation's Bylaws.

	
          RESOLVED, FURTHER, that Farid Shouekani is hereby elected to serve as a director of the Corporation, his term of office to commence immediately and continue until his successor is duly elected and qualified.

	
OMNIBUS RESOLUTIONS

	
          RESOLVED, that the appropriate officers of the Corporation are hereby authorized, empowered and directed to do or cause to be done any and all such further acts and things, to execute any and all such further documents as they may deem necessary or advisable to effect the provisions of the Agreement and to carry out the intent and accomplish the purposes of the foregoing resolutions.

	
          RESOLVED, FURTHER, that the authority given hereunder shall be deemed retroactive and any and all acts authorized hereunder performed prior to the passage of these resolutions are hereby ratified and affirmed.

	
          This Unanimous Written Consent may be executed in one or more counterparts, each of which shall be an original and all of which together shall be one and the same instrument.  This Unanimous Written Consent shall be filed in the Minute Book of this Corporation and become a part of the records of this Corporation.

	
          IN WITNESS WHEREOF, the undersigned have executed this Unanimous Written Consent effective as of October 10, 2003.

	
 
	 	 	 	 
	
____________________________________

John Castiglione

	
 
	 	 	 	 
	
____________________________________

Jason Sunstein

	
 
	 	 	 	 
	
____________________________________

Stephen Young

	
 
	 	 	 	 
	
____________________________________

Ronald Weaver

	
 
	 	 	 	 
	
 
	 	 	 	 
	
EXHIBIT E

	
 
	 	 	 	 
	
FORM OF MID-ATLANTIC OFFICERS CERTIFICATE

	 	 	 	 	 
	
          The undersigned hereby certifies to the Viper Networks, Inc. ("Viper") that:

	 	
1.
	
I am the duly elected and acting President of Mid-Atlantic Communications, Inc., a Michigan corporation ("Mid-Atlantic").

	 	
2.
	
This Officer's Certificate is being delivered to the Viper pursuant to Sections 2.3(a) and 8.2(b) of the Agreement.

	 	
3.
	
All of the representations and warranties of Mid-Atlantic made in the Agreement are true and correct in all material respects on and as of the date hereof as though such representations and warranties had been made or given on and as of the date hereof.

	 	
4.
	
Mid-Atlantic has performed and complied in all material respects with all of the covenants and agreements made in the Agreement to be performed by or complied with by the Company on or prior to the date hereof.

	 	 	 	 	 
	
          Executed effective as of October 10, 2003.

	 	 	 	 	 
	
__________________________________________

     Farid Shouekani, President

	
 
	 	 	 	 
	
 
	 	 	 	 
	
EXHIBIT F

	
 
	 	 	 	 
	
FORM OF MID-ATLANTIC RESOLUTIONS

	
 
	 	 	 	 
	
WRITTEN CONSENT OF DIRECTORS AND SHAREHOLDERS OF

MID-ATLANTIC COMMUNICATIONS, INC.

	
 
	 	 	 	 
	
          Pursuant to the provisions of the General Corporation Law of California, the undersigned being all the shareholders and directors of Mid-Atlantic International, Inc. (the "Corporation"), a Michigan Corporation entitled to vote upon the following resolutions as if the same had been submitted at a formal meeting of the shareholders and directors of the Corporation duly called and held for the purpose of acting upon such resolutions, does hereby adopt such resolutions to the same extent and to have the same force and effect as it adopted by unanimous vote at a formal meeting of the shareholders and directors of the Corporation duly called and held for the purpose of acting upon proposals to adopt such resolutions.

	
1.
	
Approval of SECURITIES MERGER AGREEMENT

	
          NOW, THEREFORE, IT IS HEREBY

	
          RESOLVED, that the form, terms and provisions of the SECURITIES MERGER AGREEMENT dated on or about October 10, 2003 by and between Corporation and Viper Networks, Inc., a Utah Corporation (the "Agreement"), a copy of which has been reviewed by the undersigned Directors and Shareholders, be and they hereby are, in all respects approved; and it is further

	
          RESOLVED, that the officers of the Corporation be, and each of them hereby is, authorized in the name and on behalf of the Corporation to do or cause to be done all such further acts and things and to take or cause to be taken and any and all such further actions and to make, execute and deliver or cause to be made, executed and delivered any and all such documents, agreements, instruments, certificates, press releases. Filings with governmental agencies and undertakings as each such officer may deem necessary or advisable to carry into effect the purposes and intent of the foregoing resolution and the transactions contemplated thereby, and to perform or cause to be performed any agreement related thereto and any other agreement referred to herein or contemplated or authorized hereby, and it is further

	
          RESOLVED, that any and all actions heretofore or hereafter taken by any officer, agent or employee of the Corporation within the terms of the foregoing resolutions be and they, hereby are ratified, confirmed, authorized and approved as the deed of the Corporation, and further

	
          RESOLVED, that the Secretary and Assistant Secretary of the Corporation be and each of them is hereby authorized and empowered to certify as to all matters pertaining to the acts, transactions or agreements contemplated in the foregoing resolutions.

	
 
	 
	 	
____________________________________

Farid Souekani

	
 
	 
	 	
____________________________________

All the Directors and Shareholders of

Mid-Atlantic International, Inc.

	
 
	 	 	 	 
	
 
	 	 	 	 
	
EXHIBIT G

	
 
	 	 	 	 
	
LIST OF ASSETS OF SELLER

	
 
	 	 	 	 
	
Current Assets (Estimated $600,000):

	
Switching:

Nextone license 1500 ports.

Rodopi VoIP calling card

SIP Proxy - SoftPhone

Web based billing and monitoring system

	
VSAT:

One 1.8 Ku in Morocco stations

One 1.8 KU in Egypt station

One 2.4 C band in Jordan station

One 2.4 Meter dish Egypt

	
Routers:

One 5350 2E1 in Egypt, one 2600, one Switch 2924

One 5350 2E1 in UK

One 5350 2T1 in Seattle, one Switch 2924

One 3620 in MI,

One 5350 chassis in MI

One 5350 4T1 in NJ

	
Three T1 D2400 Quintum in Sri Lanka, Switch 2912

Ten Quintum A800 in Ghana, two Switches 2924

Two Quintum A800 in India

Three Quintum A800 In Srilanka

	
Two Cisco 1750

	
Channle Banks:

Two CAC in Saudi

One Adtran in Seattle

Two Adtran in UK

Two Adtran in Jamaica

Two CAC in UK

One Adtran in MI

	
Cell Phone Terminals:

18 Nokia Premicell in Saudi

10 Nokia 22 in Saudi

72 Nokia 22 in Jamaica

47 Noika 22 in Sri Lanka

21 Nokia Preicell in India

3 Nokia 22 in Inida

	
Wireless Links:

One link for 4 E1 Wavepoint (voice) with modems - in Nigeria

	
Computers/Servers:

One Sun Netra 1405

One Dell Power Edge 2650 (NARS)

Two Intel for Nextone P4

Five VPR Matrix servers (data)

Two Network servers

Two Compaq Rodopi servers

One Compaq Gold server

One Compaq Softphone servers 

One HP laptop

	
 
	 	 	 	 
	
CERTIFIED:

____________________________

Farid Shouekani, President

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00083-of-00352.parquet"}]]